Adero Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $269K | Sell |
3,878
-1,469
| -27% | -$102K | 0.02% | 192 |
|
|
2024
Q4 | $460K | Sell |
5,347
-601
| -10% | -$51.7K | 0.03% | 132 |
|
|
2024
Q3 | $708K | Buy |
5,948
+792
| +15% | +$94.3K | 0.05% | 103 |
|
|
2024
Q2 | $736K | Buy |
5,156
+200
| +4% | +$28.5K | 0.05% | 96 |
|
|
2024
Q1 | $636K | Buy |
4,956
+1,265
| +34% | +$162K | 0.05% | 99 |
|
|
2023
Q4 | $382K | Sell |
3,691
-48
| -1% | -$4.97K | 0.03% | 130 |
|
|
2023
Q3 | $340K | Buy |
3,739
+1,073
| +40% | +$97.6K | 0.03% | 136 |
|
|
2023
Q2 | $216K | Sell |
2,666
-82
| -3% | -$6.63K | 0.02% | 152 |
|
|
2023
Q1 | $219K | Sell |
2,748
-234
| -8% | -$18.6K | 0.02% | 145 |
|
|
2022
Q4 | $202K | Buy |
+2,982
| New | +$202K | 0.02% | 151 |
|
|
2022
Q1 | – | Sell |
-3,576
| Closed | -$200K | – | 162 |
|
|
2021
Q4 | $200K | Buy |
+3,576
| New | +$200K | 0.03% | 152 |
|